Showing results (61-70 of 153) with videos related to

Sort By:
Pageof 16
Pharmaceuticals (Basel, Switzerland)|April 28, 2023
Imageological/Structural Study regarding the Improved Pharmacokinetics by <sup>68</sup>Ga-Labeled PEGylated PSMA Multimer in Prostate CancerHuihui Zhang, Maohua Rao, Huayi Zhao, et al.
Oncotarget|September 12, 2015
Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survivalLi-Ru He, Ning-Fang Ma, Jie-Wei Chen, et al.
Small (Weinheim an Der Bergstrasse, Germany)|June 7, 2023
Construction of Microfluidic Chip Structure for Cell Migration Studies in Bioactive CeramicsSheng Ye, Quanle Cao, Panxianzhi Ni, et al.
Pharmaceutical Research|September 12, 2014
Azithromycin cationic non-lecithoid nano/microparticles improve bioavailability and targeting efficiencyMeng Zhong, Yue Feng, Hong Liao, et al.
Oncology Letters|March 31, 2017
P300 promotes migration, invasion and epithelial-mesenchymal transition in a nasopharyngeal carcinoma cell lineZhi-Wei Liao, Lei Zhao, Mu-Yan Cai, et al.
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi = Chinese Journal of Otorhinolaryngology Head and Neck Surgery|December 20, 2011
[Clinical analysis of 6 cases of primary small cell carcinoma of the larynx]Tao Xu, Yuan-hong Gao, Ping Chen, et al.
Journal of Cancer|November 21, 2017
Comparative Outcomes of Induction Chemotherapy Followed By Definitive Chemoradiotherapy versus Chemoradiotherapy Alone In Esophageal Squamous Cell CarcinomaLi-Ling Luo, Mian Xi, Ya-Di Yang, et al.
Journal of Cancer|September 27, 2014
The modified glasgow prognostic score is an independent prognostic factor in patients with inoperable thoracic esophageal squamous cell carcinoma undergoing chemoradiotherapyPeng Zhang, Mian Xi, Qiao-Qiao Li, et al.
Plos One|August 19, 2014
Is there a benefit in receiving concurrent chemoradiotherapy for elderly patients with inoperable thoracic esophageal squamous cell carcinoma?Peng Zhang, Mian Xi, Lei Zhao, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 10, 2015
Polymorphisms of insulin-like growth factor binding protein-3 as a predictor for risk and patient survival in esophageal squamous cell carcinomaLei Zhao, Feng Chi, Mian Xi, et al.
Pageof 16